{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:19:57Z","timestamp":1757621997113,"version":"3.44.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-13673-1","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T21:31:23Z","timestamp":1754343083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and patterns of antiretroviral resistance in HIV-infected Latin American asylum seekers"],"prefix":"10.1038","volume":"15","author":[{"given":"Samuel","family":"Manzano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Torres-Macho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neda","family":"Deihim-Rahampour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Cuevas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Perez-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luz","family":"Balsalobre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvador","family":"Resino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilde","family":"Sanchez-Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"13673_CR1","unstructured":"Hoja informativa \u2014. \u00daltimas estad\u00edsticas sobre el estado de la epidemia de sida [Internet]. [citado 16 de septiembre de 2024]. Disponible en: https:\/\/www.unaids.org\/es\/resources\/fact-sheet"},{"key":"13673_CR2","unstructured":"By-Nc-Sa, C. Unidad de vigilancia de VIH, ITS y hepatitis. Vigilancia Epidemiol\u00f3gica del VIH y sida en Espa\u00f1a. : Sistema de Informaci\u00f3n sobre Nuevos Diagn\u00f3sticos de VIH y Registro Nacional de Casos de Sida. Centro Nacional de Epidemiolog\u00eda. Instituto de Salud Carlos III\/ Divisi\u00f3n de control de VIH, ITS, Hepatitis virales y tuberculosis. Ministerio de Sanidad. Madrid; noviembre 2024. (2023)."},{"key":"13673_CR3","unstructured":"European Commission. Eurostat. Migration and asylum in Europe [Internet]. LU: Publications Office; 2023 [citado 18 de septiembre de 2024]. (Migration and asylum in Europe \u2026Disponible en: https:\/\/data.europa.eu\/doi\/10.2785\/353399."},{"key":"13673_CR4","unstructured":"INE [Internet]. INEbase \/ Demograf\u00eda y poblaci\u00f3n \/Fen\u00f3menos demogr\u00e1ficos \/Estad\u00edstica de Migraciones y Cambios de Residencia \/ \u00daltimos datos (&cid=1254736177098&menu=ultiDatos&idp=1254735573002, )."},{"issue":"10164","key":"13673_CR5","first-page":"2606","volume":"392","author":"I Abubakar","year":"2018","unstructured":"Abubakar, I. et al. The UCL\u2013Lancet commission on migration and health: the health of a world on the move. Lancet Lond. Engl. 15 De Diciembre De. 392 (10164), 2606\u20132654 (2018).","journal-title":"Lancet Lond. Engl. 15 De Diciembre De"},{"issue":"4","key":"13673_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/BF03403757","volume":"99","author":"C Rousseau","year":"2008","unstructured":"Rousseau, C. et al. Health care access for refugees and immigrants with precarious status. Can. J. Public. Health Rev. Can. Sant\u00e9 Publique Julio De. 99 (4), 290\u2013292 (2008).","journal-title":"Can. J. Public. Health Rev. Can. Sant\u00e9 Publique Julio De"},{"key":"13673_CR7","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1186\/s12889-023-16363-7","volume":"23","author":"SM Goldenberg","year":"2023","unstructured":"Goldenberg, S. M. & Fischer, F. Migration and health research: past, present, and future. BMC Public. Health 25 De Julio De. 23, 1425 (2023).","journal-title":"BMC Public. Health 25 De Julio De"},{"issue":"3","key":"13673_CR8","first-page":"114016","volume":"26","author":"F Camargo-Assis","year":"2024","unstructured":"Camargo-Assis, F., Lopez-Mejia, Y., Salim-Mattar, A. & Salim-Mattar Migrations in Latin america: the corridor to the American dream is a public health problem. Rev. Salud P\u00fablica 1 De Mayo De. 26 (3), 114016 (2024).","journal-title":"Rev. Salud P\u00fablica 1 De Mayo De"},{"issue":"3","key":"13673_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/QAI.0000000000003560","volume":"98","author":"A Perez-Brumer","year":"2025","unstructured":"Perez-Brumer, A. et al. Migration is associated with increased HIV vulnerability among young transgender women in lima, Peru. JAIDS J. Acquir. Immune Defic. Syndr. 1 De Marzo De. 98 (3), 199 (2025).","journal-title":"JAIDS J. Acquir. Immune Defic. Syndr. 1 De Marzo De"},{"key":"13673_CR10","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Morales, A. J., Bonilla-Aldana, D. K., Morales, M., Su\u00e1rez, J. A. & Mart\u00ednez-Buitrago, E. Migration crisis in Venezuela and its impact on HIV in other countries: the case of Colombia. Ann. Clin. Microbiol. Antimicrob. 8 de marzo de 2019;18:9.","DOI":"10.1186\/s12941-019-0310-4"},{"issue":"Suppl Suppl 4","key":"13673_CR11","doi-asserted-by":"publisher","first-page":"e25137","DOI":"10.1002\/jia2.25137","volume":"21","author":"J Vearey","year":"2018","unstructured":"Vearey, J. Moving forward: why responding to migration, mobility and HIV in South(ern) Africa is a public health priority. J. Int. AIDS Soc. 19 De Julio De. 21 (Suppl Suppl 4), e25137 (2018).","journal-title":"J. Int. AIDS Soc. 19 De Julio De"},{"issue":"29","key":"13673_CR12","first-page":"2300692","volume":"29","author":"P Ryan","year":"2024","unstructured":"Ryan, P. et al. HIV-infected Latin American asylum seekers in madrid, spain, 2022: A prospective cohort study from a major gateway in Europe. Euro. 18 De Julio De. 29 (29), 2300692 (2024).","journal-title":"Euro. 18 De Julio De"},{"key":"13673_CR13","unstructured":"Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach [Internet]. [citado 16 de septiembre de 2024]. Disponible en: https:\/\/www.who.int\/publications\/i\/item\/9789240031593"},{"key":"13673_CR14","unstructured":"Landovitz, R. J. et al. Type 1 human immunodeficiency virus (HIV-1) incidence, adherence, and drug resistance in individuals taking daily emtricitabine\/tenofovir disoproxil fumarate for HIV-1 Pre-exposure prophylaxis: pooled analysis from 72 global studies. Clin. Infect. Dis. Off Publ Infect. Dis. Soc. Am. 14 de marzo de 2024;79(5):1197\u20131207 ."},{"issue":"1","key":"13673_CR15","first-page":"43","volume":"20","author":"CA Boucher","year":"2018","unstructured":"Boucher, C. A. et al. State of the Art in HIV drug resistance: surveillance and regional gaps. AIDS Rev. 20 (1), 43\u201357 (2018).","journal-title":"AIDS Rev."},{"issue":"3","key":"13673_CR16","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1016\/S2352-3018(22)00327-7","volume":"10","author":"R Kantor","year":"2023","unstructured":"Kantor, R. & Gupta, R. K. We should not stop considering HIV drug resistance testing at failure of first-line antiretroviral therapy. Lancet HIV Marzo De. 10 (3), e202\u2013e208 (2023).","journal-title":"Lancet HIV Marzo De"},{"key":"13673_CR17","unstructured":"HIV drug resistance [Internet]. [citado 18 de septiembre de 2024]. Disponible en: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/treatment\/hiv-drug-resistance"},{"key":"13673_CR18","unstructured":"HIV drug resistance. \u2013 brief report 2024 [Internet]. [citado 18 de septiembre de 2024]. Disponible en: https:\/\/www.who.int\/publications\/i\/item\/9789240086319"},{"issue":"1","key":"13673_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5354\/0719-5281.2021.65188","volume":"25","author":"L Ortiz-Hern\u00e1ndez","year":"2021","unstructured":"Ortiz-Hern\u00e1ndez, L., P\u00e9rez-Salgado, D., Staines-Orozco, G. & Compe\u00e1n-Dard\u00f3n, S. Estigma percibido Por VIH y adherencia al Tratamiento retroviral En personas Con VIH En La Ciudad de M\u00e9xico. Rev. Chil. Salud P\u00fablica 26 De Octubre De. 25 (1), 15\u201327 (2021).","journal-title":"Rev. Chil. Salud P\u00fablica 26 De Octubre De"},{"issue":"7","key":"13673_CR20","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S1473-3099(15)00108-5","volume":"15","author":"A Pi\u00f1eir\u00faa","year":"2015","unstructured":"Pi\u00f1eir\u00faa, A. et al. The HIV care continuum in Latin america: challenges and opportunities. Lancet Infect. Dis. 1 De Julio De. 15 (7), 833\u2013839 (2015).","journal-title":"Lancet Infect. Dis. 1 De Julio De"},{"key":"13673_CR21","unstructured":"HIV drug resistance. report 2021 [Internet]. [citado 7 de octubre de 2024]. Disponible en: https:\/\/www.who.int\/publications\/i\/item\/9789240038608"},{"key":"13673_CR22","doi-asserted-by":"crossref","unstructured":"Flieller, R. et al. HIV drug resistance in adults initiating or reinitiating antiretroviral therapy in Uruguay\u2014Results of a nationally representative survey, 2018\u20132019. Viruses. 10 de febrero de 2023;15(2):490 .","DOI":"10.3390\/v15020490"},{"issue":"10","key":"13673_CR23","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1002\/jmv.27933","volume":"94","author":"G Aguilar","year":"2022","unstructured":"Aguilar, G. et al. HIV drug resistance in persons initiating or reinitiating first-line antiretroviral therapy in paraguay: results of a National patient survey. J. Med. Virol. 94 (10), 5061\u20135065 (2022).","journal-title":"J. Med. Virol."},{"key":"13673_CR24","unstructured":"CPR. Calibrated Population Resistance Tool - HIV Drug Resistance Database [Internet]. [citado 2 de octubre de 2024]. Disponible en: https:\/\/hivdb.stanford.edu\/cpr\/form\/PRRT\/"},{"key":"13673_CR25","unstructured":"Base de datos. sobre resistencia a los medicamentos contra el VIH [Internet]. [citado 2 de octubre de 2024]. Disponible en: https:\/\/hivdb.stanford.edu\/pages\/WHOResistanceList.html"},{"key":"13673_CR26","unstructured":"HIV Drug Resistance Database [Internet]. [citado 2 de octubre de 2024]. Disponible en: https:\/\/hivdb.stanford.edu\/pages\/SDRM.worksheet.NNRTI.html"},{"key":"13673_CR27","unstructured":"HIV Drug Resistance Database [Internet]. [citado 2 de octubre de 2024]. Disponible en: https:\/\/hivdb.stanford.edu\/pages\/SDRM.worksheet.NRTI.html"},{"key":"13673_CR28","unstructured":"Release Notes - HIV Drug Resistance Database [Internet]. [citado 2 de octubre de 2024]. Disponible en: https:\/\/hivdb.stanford.edu\/page\/release-notes\/#drm.penalty.scores.and.resistance.interpretation"},{"issue":"2","key":"13673_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris, P. A. et al. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inf. Abril De. 42 (2), 377\u2013381 (2009).","journal-title":"J. Biomed. Inf. Abril De"},{"key":"13673_CR30","doi-asserted-by":"crossref","unstructured":"Vega, Y. et al. Epidemiological surveillance of HIV-1 transmitted drug resistance in Spain in 2004\u20132012: relevance of transmission clusters in the propagation of resistance mutations. PLOS ONE. 26 de mayo de 2015;10(5):e0125699 .","DOI":"10.1371\/journal.pone.0125699"},{"issue":"12","key":"13673_CR31","doi-asserted-by":"publisher","first-page":"e29287","DOI":"10.1002\/jmv.29287","volume":"95","author":"L Vi\u00f1uela","year":"2023","unstructured":"Vi\u00f1uela, L. et al. Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019\u20132021. J. Med. Virol. 95 (12), e29287 (2023).","journal-title":"J. Med. Virol."},{"issue":"10","key":"13673_CR32","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1128\/AAC.37.10.2231","volume":"37","author":"CA Boucher","year":"1993","unstructured":"Boucher, C. A. et al. High-level resistance to (-) enantiomeric 2\u2019-deoxy-3\u2019-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase. Antimicrob. Agents Chemother. Octubre De. 37 (10), 2231\u20132234 (1993).","journal-title":"Antimicrob. Agents Chemother. Octubre De"},{"key":"13673_CR33","unstructured":"documento_sobre_interpretacion_y_utilidad_clinica.pdf [Internet]. [citado 17 de marzo de 2025]. Disponible en: https:\/\/gesida-seimc.org\/wp-content\/uploads\/2024\/01\/documento_sobre_interpretacion_y_utilidad_clinica.pdf"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13673-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13673-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13673-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:34:30Z","timestamp":1757349270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13673-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13673"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-13673-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"3 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study complied with the Declaration of Helsinki and adhered to the STROBE guidelines for reporting observational studies (see Supplementary Material). The study protocol was approved by the Infanta Leonor Hospital Research Ethics Board in 2022 and was registered at ClinicalTrials.gov (NCT05998499). Informed consent was obtained from all participants prior to inclusion.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"28346"}}